Your session is about to expire
← Back to Search
Other
LabClasp Wearable Device for Monitoring in Healthy Individuals
N/A
Waitlist Available
Led By Virend Somers
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day
Awards & highlights
Study Summary
This trial tests whether the LabClasp, a wearable device, can accurately measure blood lactate levels.
Who is the study for?
This trial is for healthy adults over 18 who can do high-intensity exercise, are not smokers, haven't been hospitalized recently, aren't in the ICU but have sepsis risk factors. They must be able to consent and agree to regular blood tests for lactate levels.Check my eligibility
What is being tested?
The study is testing LabClasp's technology to estimate blood lactate levels non-invasively during high-intensity exercise compared with traditional blood sampling methods.See study design
What are the potential side effects?
Since this trial involves non-invasive monitoring with LabClasp and regular blood draws, potential side effects may include discomfort at the sensor site and bruising or pain from blood sampling.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 day
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Blood [lactate] during incremental exercise
Blood [lactate] measurements in ICU patients
Trial Design
2Treatment groups
Experimental Treatment
Group I: Whole-body exercise in healthy adults (Aim 1)Experimental Treatment1 Intervention
Subjects will have blood [lactate] measurement obtained with the LabClasp device while completing an exercise stress test on a treadmill or bicycle.
Group II: ICU patients susceptible to developing sepsis (Aim 2)Experimental Treatment1 Intervention
Subjects will have blood [lactate] measurement obtained with the LabClasp device as frequently as required for clinical purposes
Find a Location
Who is running the clinical trial?
Mayo ClinicLead Sponsor
3,176 Previous Clinical Trials
3,758,001 Total Patients Enrolled
Virend SomersPrincipal InvestigatorMayo Clinic
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I haven't been hospitalized in the last 60 days.I am 18 years old or older.I am HIV positive and on antiretroviral treatment.I am 18 years old or older.I have or had another type of cancer.
Research Study Groups:
This trial has the following groups:- Group 1: Whole-body exercise in healthy adults (Aim 1)
- Group 2: ICU patients susceptible to developing sepsis (Aim 2)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this experiment currently in the process of enrolling participants?
"The data hosted on clinicaltrials.gov confirms that this particular medical trial is not currently accepting patients, having been posted on February 1st 2023 and last updated October 14th 2022. Nevertheless, there are 839 other trials actively recruiting participants as of now."
Answered by AI
Share this study with friends
Copy Link
Messenger